Loosen, S., Bergmann, F., & Longerich, T. (2019). High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma. Carcinogenesis, 40(8), . https://doi.org/10.1093/carcin/bgz033
Chicago-Zitierstil (17. Ausg.)Loosen, Sven, Frank Bergmann, und Thomas Longerich. "High Baseline Soluble Urokinase Plasminogen Activator Receptor (suPAR) Serum Levels Indicate Adverse Outcome After Resection of Pancreatic Adenocarcinoma." Carcinogenesis 40, no. 8 (2019). https://doi.org/10.1093/carcin/bgz033.
MLA-Zitierstil (9. Ausg.)Loosen, Sven, et al. "High Baseline Soluble Urokinase Plasminogen Activator Receptor (suPAR) Serum Levels Indicate Adverse Outcome After Resection of Pancreatic Adenocarcinoma." Carcinogenesis, vol. 40, no. 8, 2019, https://doi.org/10.1093/carcin/bgz033.